Medtech companies directory 2026

    Medical Device Companies in South Korea

    Korean hospital technology is a reimbursement market wearing an export-industry face: MFDS clearance puts a device on the legal shelf, an NHIS or HIRA code puts it on the claim, and the five big hospital systems (Asan, Samsung Medical Center, Severance, Seoul National, St. Mary’s) decide whether the SKU ever reaches a tertiary tray.

    Samsung Medison, Alpinion, Osstem, Vatech, Lunit and Seegene are the Korean houses a biomedical engineer and a laboratory director already know — ultrasound, implants, dental imaging, AI readout, molecular IVD. Siemens Healthineers Korea holds a large imaging and lab installed base beside GE and Philips seats. The Ministry of Food and Drug Safety is the device gate; the National Health Insurance Service and HIRA write the codes that make a premium implant or an AI readout economically usable. Hospital procurement at the five majors is committee-led and brand-sticky. BioNixus interviews those named committees, not a generic “Korea hospital” cell.

    Updated September 2026 · MFDS — Ministry of Food and Drug Safety, medical device approval and surveillance as of September 2026 · 16 named accounts

    MFDS

    Ministry of Food and Drug Safety — Korean device approval and post-market owner

    NHIS / HIRA

    Insurer and review agency whose codes decide whether a premium SKU is claimable

    Big 5

    Asan, SMC, Severance, SNUH and St. Mary’s — tertiary committees that set the tray

    Export

    Korean ultrasound, dental and IVD houses that sell abroad from the same factories

    Named accounts

    Top medical device companies in South Korea

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against MFDS — Ministry of Food and Drug Safety, medical device approval and surveillance (as of 2026-09-05).
    #CompanyHQ
    01MFDS (Ministry of Food and Drug Safety)Osong
    02NHIS / HIRA hospital reimbursement and procurement overlayWonju / Seoul
    03Samsung MedisonSeoul
    04Alpinion Medical SystemsSeoul
    05Osstem ImplantSeoul
    06VatechHwaseong
    07LunitSeoul
    08SeegeneSeoul
    09Siemens Healthineers KoreaSeoul
    10GE HealthCare KoreaSeoul
    11Medtronic KoreaSeoul
    12Asan / SMC / Severance / SNUH / St. Mary’s procurementSeoul
    13Korean device importers (수입업체)Seoul / Gyeonggi
    14Philips Korea (Health Systems)Seoul
    15Secondary hospital and clinic-chain buying groupsNationwide
    16Sewoon Medical / domestic consumable makersMultiple

    Primary research

    These are the medical device companies accounts we study in South Korea

    Need account-level or SKU-level data for a brand in South Korea? BioNixus runs primary fieldwork — brand vs competitors, including the channels a dashboard averages away. Proposal ready within 48 hours of a brief.

    Planning research in South Korea?

    Primary research, market access & HEOR. Proposals within 48 hours.

    Top market research companies in South Korea (2026)

    How the market is structured

    MFDS file, HIRA code, tertiary committee

    A device that will be used on a Korean insured patient needs an MFDS licence held by a Korean manufacturer or importer, and, for anything that will be claimed, a HIRA reimbursement code or a hospital’s willingness to take it as non-covered. That second gate is where many AI and premium implant launches stall. Capital equipment — ultrasound, CT, MR, dental CBCT, laboratory automation — is specified by the department and purchased by the hospital’s equipment committee, with the Big Five systems running the most sophisticated evaluations in the country. Samsung Medison and Alpinion fight GE and Siemens on ultrasound inside those rooms; Vatech owns a large dental-imaging installed base that sits closer to clinic chains than to Asan’s radiology floor. Consumables, dental implants and IVD reagents ride a different path: Osstem has made Korean dental implant volume a domestic story; Seegene’s molecular kits sit in hospital and commercial labs on reagent-rental logic; Lunit’s AI readouts need both MFDS clearance and a HIRA or hospital-budget story before a radiology chair will keep the licence live. Siemens Healthineers Korea sells and services imaging and lab systems with a direct organisation; smaller foreign brands appoint 수입업체 who hold the MFDS file and the hospital vendor code. NHIS does not warehouse product, but its fee schedule is the commercial document BioNixus reads before a Korea forecast is signed. Export success from Wonju, Seoul and Songdo does not automatically mean Asan has adopted the same SKU.

    Local

    Korean ultrasound, dental, AI and IVD houses whose factories already feed tertiary rooms, clinic chains and export containers.

    • Samsung Medison
    • Alpinion Medical Systems
    • Osstem Implant
    • Vatech
    • Lunit
    • Seegene
    • Sewoon Medical / domestic consumable makers

    Multinational

    Seoul multinational seats that hold Big Five imaging and implant share and still share secondary-hospital invoices with 수입업체.

    • Siemens Healthineers Korea
    • GE HealthCare Korea
    • Medtronic Korea
    • Philips Korea (Health Systems)

    Regional

    Importers and secondary-hospital dealers who hold the MFDS file and the vendor code outside the five Seoul majors.

    Distributors & service partners

    MFDS as the Osong gate, NHIS and HIRA as the claim code, Big Five committees as the tertiary tray.

    • MFDS (Ministry of Food and Drug Safety)
    • NHIS / HIRA hospital reimbursement and procurement overlay
    • Asan / SMC / Severance / SNUH / St. Mary’s procurement
    • Korean device importers (수입업체)
    • Secondary hospital and clinic-chain buying groups

    What is moving

    What is moving the medical device market in South Korea

    HIRA code timing versus MFDS clearance

    A cleared AI or implant SKU that lacks a claim path dies in the budget meeting; BioNixus dates the code, not only the licence.

    Big Five capital-committee cycles

    Asan, SMC, Severance, SNUH and St. Mary’s refresh ultrasound, CT and lab automation on separate calendars that a single Seoul dinner will not unlock.

    Dental and clinic-chain volume

    Osstem and Vatech make their Korean numbers in clinics, not in Asan radiology; a tertiary-only brief under-counts the domestic champions.

    Export factories versus domestic adoption

    Wonju and Songdo export success does not mean the same SKU is on a Korean tertiary tray; BioNixus splits those two facts.

    BioNixus fieldwork

    How BioNixus studies medical device companies in South Korea

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in South Korea:
    • Big Five equipment-committee interviews treated as five buyers, never as one Seoul average.
    • HIRA-code versus MFDS-licence date checks on AI and implant SKUs that cleared but never claimed.
    • Clinic-chain CBCT and implant installed-base counts for Vatech and Osstem outside tertiary radiology.
    • 수입업체 coverage scores so a Seoul multinational seat is not counted as secondary-hospital last-mile.

    Healthcare market research in South Korea

    Questions

    Frequently Asked Questions

    How are medical devices approved in South Korea?

    MFDS in Osong licences the manufacturer or importer. Classification drives the file. A hospital committee will ask for that licence number before it opens an evaluation.

    How does NHIS reimbursement affect device use?

    HIRA codes decide whether the hospital can claim the SKU. Non-covered devices need a hospital-budget story. Many AI and premium implant launches stall on this gate, not on MFDS.

    Who are the Korean manufacturers a brief should name?

    Samsung Medison and Alpinion for ultrasound, Osstem for dental implants, Vatech for dental imaging, Lunit for AI readout, Seegene for molecular IVD.

    Do the Big Five hospitals buy the same way?

    No. Asan, Samsung Medical Center, Severance, Seoul National and St. Mary’s run separate committees and vendor codes. A win at one is not a win at five.

    What does BioNixus study on Korean device accounts?

    MFDS-to-SKU traces, HIRA-code timing interviews, Big Five committee walks, and clinic-chain installed-base counts for Osstem and Vatech.

    Is this a Korean market-share ranking?

    No. Entries are grouped by role and appear because they recur in BioNixus tertiary and clinic fieldwork; order is not turnover.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in South Korea. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: MFDS — Ministry of Food and Drug Safety, medical device approval and surveillance, consulted 2026-09-05. Company classification (Local / MNC / Regional / distributors & service partners) reflects ownership and role in South Korea, not size.

    • MFDS medical-device approval and post-market notices, consulted 2026
    • NHIS and HIRA reimbursement-code and claim-review publications
    • Samsung Medison, Alpinion, Osstem, Vatech, Lunit and Seegene published company descriptions
    • BioNixus Korea Big Five and clinic-chain hospital fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need device-level competitive data in South Korea?

    Installed base, procedure volumes, surgeon preference and tender outcomes by hospital — fielded across public and private operators.

    Planning research in South Korea?

    Primary research, market access & HEOR. Proposals within 48 hours.